The case for & against
Bull & Bear analysis
Bearish
Braskem S.A. (NYSE: BAK) is a leading petrochemical company in Latin America, chiefly engaged in producing thermoplastic resins and industrial chemicals. The company operates across multiple segments, including Brazil, the United States, and Europe. Braskem has emphasized its strategic focus on sustainability, leveraging its resources towards green chemicals and renewable feedstocks, as well as navigating the challenges posed by geopolitical tensions and fluctuating feedstock prices in the volatile petrochemical industry.
Bull says
- ↑Q2 2026 recurring EBITDA of $1.043 B (+82% YoY)
- ↑Liquidity at $2.1 B in Q1 2026 supports operations
- ↑Sustainability push: 60% non-NAFTA feedstock target by 2030
- ↑80% Brazil plant utilization driving recovery
- ↑Dividend yield of 1.28% returns capital
- ↑Strong growth fundamentals and high dividend yield factor
Bear says
- ↓Leverage ratio of 14.74× raises financial flexibility concerns
- ↓Negative profitability factors indicate weak margin generation
- ↓Q1 2026 operating cash burn of $603 M strains liquidity
- ↓Industry downturn likely to persist through 2030
- ↓Strong Sell consensus and negative earnings revisions signal risk
- ↓Low earnings yield and deteriorating revisions factors weigh on stock
Earnings Call · Q2 2025 · Mgmt. Guidance
Updated 09-06-2026bearish
Transcript signals
Bull points
- the relocation and compensation front continued to show evolution in its indicators and ended the semester with 99.9% of execution of the resident relocation program. The same percentage also applies to the number of proposals submitted for the financial compensation and relocation support program, of which about 99.5% were accepted and 99.4% were paid.
Bear points
- The performance of the industry continues to be affected by the continuation of the downturn in the petrochemical industry in addition to the global tariff uncertainties.
- In addition, Breskin recorded an average global accident frequency rate of 1.11 events per million hours worked, well below the global industry average, which reinforces the non-negotiable commitment to the safety of the company's operations.
- recurring EBITDA of $74 million, 67% lower when compared to the first quarter of 2025, in face of a challenging conjunctural scenario.
Read full transcript analysis ›